Skip to main content
Equibles
BBNX logo

BBNX · Beta Bionics, Inc. · Analyst Estimates

Track BBNX — free

Use BBNX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BBNX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$17.75 -3.64 (-17.02%) Q1 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$962.33M
Shares
54.37M
Volume · Oct 28 2.46M Avg daily vol (3M) 1.31M

Analyst Estimates

Compare analyst forecasts for Beta Bionics, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-10-28 18:26 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-2.06
-1.88
-1.61
3
-1.84
-1.90
-1.90
-2.11
0
0
1
1
Revenue
USD
Publication date not stated
122.00M
124.36M
126.00M
10
 — — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-2.49
-2.16
-1.83
3
-2.33
-2.32
-2.32
-2.39
1
1
0
0
Revenue
USD
Publication date not stated
169.88M
182.64M
192.00M
14
 — — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.52
-0.44
-0.40
3
-0.46
-0.51
-0.51
-0.57
0
0
1
1
Revenue
USD
Publication date not stated
28.00M
30.15M
33.00M
10
 — — — — — — — —

Q ending 2027-03-31

Analyst estimates for Q ending 2027-03-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.57
-0.53
-0.49
2
-0.56
-0.56
-0.58
-0.58
0
0
1
1
Revenue
USD
Publication date not stated
32.40M
36.06M
40.99M
10
 — — — — — — — —
Key facts CIK 1674632 CUSIP 08659B102 13F (30d) 22 filings 22 filers Visit website Investor relations